Long-term safety and maintenance of efficacy of sodium oxybate in the treatment of narcolepsy with cataplexy in pediatric patients
Michel Lecendreux(Laboratoire National de Référence), Emmanuel Mignot(Palo Alto University), Diane Guinta(Jazz Pharmaceuticals (United States)), Y. Grace Wang(Jazz Pharmaceuticals (United States)), Chad Ruoff(Stanford Medicine), Giuseppe Plazzi(Istituto delle Scienze Neurologiche di Bologna), Yves Dauvilliers(Inserm), Carol L. Rosen(Rainbow Babies & Children's Hospital), Jed Black(Jazz Pharmaceuticals (United States)), Rupa Parvataneni(UCSF Helen Diller Family Comprehensive Cancer Center)
Cited by 92
Related Papers
Climate change projections using the IPSL-CM5 Earth System Model: from CMIP3 to CMIP5
|Climate Dynamics|2013|1.9k
National Sleep Foundation's sleep quality recommendations: first report
|Sleep Health|2016|1.3k
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study
|Brain|2019|1.1k
Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis
|The Lancet|2016|1k
Narcolepsy with cataplexy
|The Lancet|2007|716